XBIT News and Press, XBiotech Inc. From 04/03/20

XBiotech (NASDAQ: XBIT ) will collaborate with non-profit BioBridge Global in an FDA program to collect and distribute convalescent plasma from people who have recovered from COVID-19 infection. More news on: XBiotech Inc., Healthcare stocks news, Stocks on the move, Read more ...

AUSTIN, Texas, April 03, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) and BioBridge Global today announced their collaboration to participate in a U.S. Food and Drug Administration (FDA) investigational program for U.S. blood centers to begin collecting and distributing convalescen...

Introduction: XBiotech Inc. ( XBIT ) is a pre-market biopharmaceutical company. They are in the business of trying to develop and commercialize “True Human”™ monoclonal antibodies to treat various diseases including type 2 diabetes, infectious diseases, cardiovasc...

AUSTIN, Texas, Feb. 19, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) today announced the final results of its “modified Dutch auction” tender offer, which expired at 5:00 p.m., New York City time, on February 12, 2020. Based on the final ...

AUSTIN, Texas, Feb. 13, 2020 (GLOBE NEWSWIRE) -- This press release corrects a prior version published on February 13, 2020 and is updated to revise the preliminary proration factor.  The corrected press release reads: XBiotech Announces Preliminary Results of Tender Offer XBiotec...

Gainers:  CounterPath (NASDAQ: CPAH ) +32% . More news on: CounterPath Corporation, Genprex, Inc., Happiness Biotech Group Limited, Stocks on the move, , Read more ...

After  XBiotech (NASDAQ: XBIT) announced that investors tendering shares as part of its buyback will be able to tender only 30.9 shares for every 100 desired, shares are down 23.4% as of 11:30 a.m. EST on Thursday. In December, XBiotech completed the sale of its only clinical-stage...

XBiotech (NASDAQ: XBIT )  -26%  on preliminary results of tender offer . More news on: XBiotech Inc., Akorn, Inc., Catalyst Biosciences, Inc., Stocks on the move, , Read more ...

XBiotech (NASDAQ: XBIT ) slumps  30%  premarket on average volume on the heels of preliminary results from its tender offer announced a month ago. More news on: XBiotech Inc., Healthcare stocks news, Stocks on the move, Read more ...

AUSTIN, Texas, Feb. 13, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) (“XBiotech”) today announced the preliminary results of its “modified Dutch auction” tender offer, which expired at 5:00 p.m., New York City time, on February 12, 2020. Based on the pre...